[1] IOR, Mol Oncol, Bellinzona, Switzerland
[2] Royal Marsden NHS Fdn Trust, Canc Biomarkers Team, Sutton, Surrey, England
[3] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland
[4] IMED Oncol AstraZeneca, Li Ka Shing Ctr, Cambridge, England
[5] Royal Marsden Hosp, Inst Canc Res, Prostate Canc Targeted Therapy Grp, Div Clin Studies, Sutton, Surrey, England
[6] IOR IOSI, Mol Oncol, Bellinzona, Switzerland